Literature DB >> 34338486

Pericarditis and pericardial effusion: one or two distinct diseases?

George Lazaros1, Emilia Lazarou2, Charalambos Vlachopoulos2, Alexios Antonopoulos2, Konstantinos Tsioufis2.   

Abstract

The main pericardial syndromes include acute and recurrent pericarditis, constrictive pericarditis, and chronic pericardial effusion in the absence of overt inflammation. Despite recent advances in pericardial syndromes, certain clinical scenarios depict remarkable peculiarities, and their management is often challenging for the clinician. Acute pericarditis is the most common pericardial disease and in most instances is accompanied by pericardial effusion. On the other hand, pericardial effusion may appear as a separate clinical entity occasionally characterized by absence of inflammatory markers elevation. In cases that effusions are accompanied by C-reactive protein (CRP) elevation, the administration of empiric anti-inflammatory treatment as in acute pericarditis, is the guidelines recommended approach. Conversely, the optimal management of patients with pericardial effusions in the absence of clinical or subclinical inflammation (as depicted by CRP levels and cardiac magnetic resonance findings), is not supported by solid evidence. Patients with chronic pericardial effusions should be followed in specialized centers according to tailored timelines, based on the specific clinical scenarios which should consider etiology, effusion size, disease duration and stability as regards symptoms and effusion volume. Patients should also be advised to seek medical care at any time if symptoms like chest pain, dyspnea and fatigue should appear.

Entities:  

Mesh:

Year:  2021        PMID: 34338486     DOI: 10.23736/S2724-5683.21.05721-5

Source DB:  PubMed          Journal:  Minerva Cardiol Angiol        ISSN: 2724-5683


  1 in total

1.  Right Heart Failure With Recurrent Pericardial Effusion Mimicking Effusive-Constrictive Pericarditis Several Years After Renal Transplantation.

Authors:  Andres Cordova Sanchez; Mostafa Vasigh; Ravi Singh; Adriana May; Mehdi Marvasti; Sakti Pada Mookherjee
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.